SEC Form 4 · accession 0001232524-15-000126
Jazz Pharmaceuticals plc · JAZZ
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Suzanne Sawochka Hooper
Officer — EVP & General Counsel
Period of report
Jun 9, 2015
Accepted (ET)
Jun 11, 2015 · 5:37 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001232524
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary SharesF1 | Jun 9, 2015 | M | 4,000 | $46.83 | A | 50,420 | D | |
| Ordinary Shares | Jun 9, 2015 | S | 4,000 | $173.16 | D | 46,420 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (right to buy)F3 | $46.83 | Jun 9, 2015 | M | 4,000 | D | — | Aug 8, 2022 | Ordinary Shares | 4,000 | 42,632 | D |
Explanation of responses
- F1Includes 123 ordinary shares acquired under a Section 423 Employee Stock Purchase Plan on May 29, 2015.
- F2The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
- F3As of the date of this report, the remaining ordinary shares subject to this option are vested with respect to 25,417 shares and will vest with respect to 7,683 shares in equal monthly installments from July 9, 2015 to December 9, 2015 and with respect to 9,532 shares in equal monthly installments from January 9, 2016 to August 9, 2016.